1Heimrath J, Krawczenko A, Dus D. PIH is associated with an increase of trophoblasts circulating in maternal blood. Ginekol Pol ,2000, 7 I(4):251-254.
2Bahado-Singh RO, Oz AU. Kingston JM. et al. The role of hyperglycosylated hCG in trophoblast invasion and the prediction of subsequent pre-eclampsia. Prenat Diagn ,2002,22(6):478-481.
3Goldman-Wolff DS,Ariel I, Greenfield C,et al. Lack of human leukocyte antigen-G expression in extravillous trophoblasts is associated with pre-eclampsia. Mol Hum Reprod,2000,6( I):88-95.
4Kanayama N.Trophoblastic injury: new etiological and pathological concept of preeclampsia.Croat Med J ,2003,44(2): 148-156.
5Rein DT, Schondorf T, Gohring UJ,et al. Cytokine expression in peripheral blood lymphocytes indicates a switch to T(HELPER) cells in patients with preeclampsia. J Reprod Immunol, 2002, 54(1-2):133-142.
6Wilczynski JR, Tchorzewski H, Glowacka E,et al. Cytokine secretion by decidual lymphocytes in transient hypertension of pregnancy and pre-eclampsia. Mediators Inflamm ,2002, 11(2): 105-111.
7Hennessy A,Pilmore HL, Simmons LA,et al. A Deficiency Of Placental II-10 In Preeclampsia. Immunology, 1999, 163(6): 3491 - 3495.
8Del Gobbo V, Giganti MG, Zenobi R,et al. The immunosuppressive eytokines influence the fetal survival in patients with pregnancy-induced hypertension. Am J Reprod Immunol, 2000, 44(4):214-221.
9Williams MA, Farrand A, Mittendorf R,et al. Maternal second trimester serum tumor necrosis factor-alpha-soluble receptor p55(sTNFp55) and subsequent risk of preeclampsia. Am J Epidemiol,1999,149(4):323-329.
10Vissor W, Beckmann I, Knook MA,et al.Soluble tumor necrosis factor receptor II and soluble cell adhesion molecule 1 as markers of tumor necrosis factor-alpha release in preeclampsia. Acta Obstet Gynecol Stand ,2002, 81 (8):713 -719.